Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Sci Rep ; 13(1): 8360, 2023 05 24.
Article in English | MEDLINE | ID: covidwho-20239521

ABSTRACT

SARS-CoV-2 vaccines are useful tools to combat the Coronavirus Disease 2019 (COVID-19) pandemic, but vaccine reluctance threatens these vaccines' effectiveness. To address COVID-19 vaccine reluctance and ensure equitable distribution, understanding the extent of and factors associated with vaccine acceptance and uptake is critical. We report the results of a large nationwide study in the US conducted December 2020-May 2021 of 36,711 users from COVID-19-focused smartphone-based app How We Feel on their willingness to receive a COVID-19 vaccine. We identified sociodemographic and behavioral factors that were associated with COVID-19 vaccine acceptance and uptake, and we found several vulnerable groups at increased risk of COVID-19 burden, morbidity, and mortality were more likely to be reluctant to accept a vaccine and had lower rates of vaccination. Our findings highlight specific populations in which targeted efforts to develop education and outreach programs are needed to overcome poor vaccine acceptance and improve equitable access, diversity, and inclusion in the national response to COVID-19.


Subject(s)
COVID-19 Vaccines , COVID-19 , Humans , COVID-19/epidemiology , COVID-19/prevention & control , SARS-CoV-2 , Biological Transport , Educational Status
2.
Clin Infect Dis ; 2022 Aug 05.
Article in English | MEDLINE | ID: covidwho-2230055

ABSTRACT

BACKGROUND: Prior to the COVID-19 pandemic, crowded and unsanitary living conditions lacking medical expertise made U.S. detention centers hotbeds for infectious disease outbreaks. There have been 30,000 COVID-19 cases, positivity rates exceeding 50%, and nine deaths in Immigration and Customs Enforcement (ICE) custody, but the extent of disease among children under the care of the Office of Refugee Resettlement (ORR) has not been well-documented. We sought to evaluate the burden of COVID-19 among unaccompanied minors under the ORR's responsibility. METHODS: We analyzed SARS-CoV-2 testing results of refugees and asylum seekers in facilities associated with the ORR from 02/01/2020 to 11/18/2020, courtesy of a Freedom of Information Act request. RESULTS: ORR facilities performed 7,132 SARS-CoV-2 tests from 3/13/2020 to 11/18/2020. Overall, the SARS-CoV-2 positivity rate was 13.4%. Factors associated with higher positivity rates were age group (16 to 17 years old); identifying as male; undergoing testing in April, August, or September; staying in a for-profit versus a non-profit facility, and detention in certain facilities. The mean detention time with a positive test was 14.8 ± 3.2 days. Greater than 10 percent of positive tests were in long-term detainees. CONCLUSIONS: The high SARS-CoV-2 test positivity rate raises concerns about an inability to limit the spread of SARS-CoV-2 within detention facilities housing unaccompanied migrant children, particularly those run by for-profit companies. Mandated measures for social distancing and vaccination among detainees and detention facility employees are needed to limit the spread of the virus.

3.
Am J Trop Med Hyg ; 104(1): 32-34, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1061312

ABSTRACT

Minority communities have borne the brunt of COVID-19 disease in the United States. Nonwhites have contracted most of the SARS-CoV-2 infections; COVID-19 mortality rates for Black Americans are more than twice those for whites. Given this, studying the most effective ways to prevent and treat SARS-CoV-2 in these populations should be a research priority, particularly with respect to vaccine trials. Federal guidelines from the National Institutes of Health and Food and Drug Administration emphasize the need for inclusion of minority groups in these trials, but none of the publicly available SARS-CoV-2 vaccine trial protocols requires representative sampling of minorities. This piece emphasizes the importance of adequate inclusion of minority communities in SARS-CoV-2 vaccine trials, and the implications of this inclusion for SARS-CoV-2 vaccine distribution.


Subject(s)
COVID-19 Vaccines/immunology , COVID-19/epidemiology , COVID-19/prevention & control , Clinical Trials as Topic/organization & administration , Minority Groups , SARS-CoV-2/immunology , Black or African American , Clinical Trials as Topic/standards , Ethnicity/statistics & numerical data , Healthcare Disparities , Hispanic or Latino , Humans , Research Design , United States/epidemiology , American Indian or Alaska Native
5.
Nat Hum Behav ; 4(9): 972-982, 2020 09.
Article in English | MEDLINE | ID: covidwho-733521

ABSTRACT

Despite the widespread implementation of public health measures, coronavirus disease 2019 (COVID-19) continues to spread in the United States. To facilitate an agile response to the pandemic, we developed How We Feel, a web and mobile application that collects longitudinal self-reported survey responses on health, behaviour and demographics. Here, we report results from over 500,000 users in the United States from 2 April 2020 to 12 May 2020. We show that self-reported surveys can be used to build predictive models to identify likely COVID-19-positive individuals. We find evidence among our users for asymptomatic or presymptomatic presentation; show a variety of exposure, occupational and demographic risk factors for COVID-19 beyond symptoms; reveal factors for which users have been SARS-CoV-2 PCR tested; and highlight the temporal dynamics of symptoms and self-isolation behaviour. These results highlight the utility of collecting a diverse set of symptomatic, demographic, exposure and behavioural self-reported data to fight the COVID-19 pandemic.


Subject(s)
Betacoronavirus , Clinical Laboratory Techniques/statistics & numerical data , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Adult , Asymptomatic Diseases/epidemiology , COVID-19 , COVID-19 Testing , Coronavirus Infections/diagnosis , Coronavirus Infections/prevention & control , Coronavirus Infections/psychology , Female , Humans , Longitudinal Studies , Male , Mobile Applications , Models, Statistical , Pandemics/prevention & control , Pandemics/statistics & numerical data , Pneumonia, Viral/diagnosis , Pneumonia, Viral/prevention & control , Pneumonia, Viral/psychology , SARS-CoV-2 , United States/epidemiology
6.
Am J Trop Med Hyg ; 103(2): 578-580, 2020 08.
Article in English | MEDLINE | ID: covidwho-538611

ABSTRACT

As COVID-19 has spread across the globe, quarantines and sheltering-in-place orders have become important public health tools but, as currently implemented, have eroded human rights, particularly for the marginalized, including essential workers, detainees, women, and children. Quarantines and sheltering-in-place orders must include explicit guarantees of human rights protections. We outline protections for the quarantined that communities and governments should strive to guarantee.


Subject(s)
Coronavirus Infections/epidemiology , Human Rights , Pneumonia, Viral/epidemiology , Quarantine , Betacoronavirus , COVID-19 , Child , Coronavirus Infections/prevention & control , Female , Humans , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Prisoners , Refugees , SARS-CoV-2 , Safety , Vulnerable Populations , Women , Workforce
7.
Clin Infect Dis ; 72(1): 153-154, 2021 01 23.
Article in English | MEDLINE | ID: covidwho-436454

ABSTRACT

There have been several significant outbreaks of COVID-19 in federal immigrant detention centers, which lack clear and consistent guidelines across Department of Homeland Security (DHS) agencies to limit the spread of COVID-19. The Centers for Disease Control and Prevention (CDC) has issued detailed guidelines for the control, prevention, and evaluation of COVID-19 in detention facilities. Although the DHS's Immigration and Customs Enforcement agency has stated that it complies with CDC recommendations, its policies significantly differ from these CDC guidelines, placing detainees at risk for contracting COVID-19. This submission urges the adoption of CDC guidelines across DHS-associated facilities. Such a policy change has the potential to protect and save the lives of the most vulnerable populations under the auspices of the federal government.


Subject(s)
COVID-19 , Emigrants and Immigrants , Centers for Disease Control and Prevention, U.S. , Disease Outbreaks , Humans , SARS-CoV-2 , United States
SELECTION OF CITATIONS
SEARCH DETAIL